DF in making patient-specific bone

Gordana Vunjak Novakovic

Gordana Vunjak‐Novakovic is the Mikati Foundation Professor of Biomedical Engineering and
Professor of Medical Sciences at Columbia University, where she directs the Laboratory for
Stem Cells and Tissue Engineering. The focus of her research is on engineering human tissues
regenerative medicine, stem cell research and modeling of disease. She has over 70 licensed,
issued and pending patents, and has founded three biotech companies – epiBone, Tara
Biosystems, and MatriTek, and is a frequent advisor to government and industry. She is a
member of the National Academy of Engineering, the National Academy of Medicine, and the
National Academy of Inventors.

EpiBone is a bone reconstruction company that allows patients to “grow their own bone”. Our
pioneering technology utilizes a scan of the patient’s bone defect and the patient’s own stem
cells to construct and cultivate a defect‐specific autologous‐like bone graft. Epibone is
strategically positioned to provide bone grafts that will provide exact defect repair, a simplified
surgical procedure, improved bone formation and regeneration, and shorter recovery times,
without the complications of foreign body implantation, to the over 900,000 patients who
undergo bone‐related surgeries each year